Anthropocene Ventures

Anthro Ventures is an early-stage venture capital firm focused on transforming healthcare and life sciences. The fund aims to improve patient outcomes while simultaneously reducing healthcare costs by investing in innovative, cutting-edge technologies. Anthro Ventures has made notable investments in companies such as Hannah Life Technologies and Ride Health, which align with their goal of addressing unmet clinical needs. Their investment strategy targets early-stage companies—primarily in pre-seed, seed, and Series A rounds. They focus on startups developing impactful medical devices, diagnostics, and digital health solutions. Geographically, their investments span both the U.S. and international markets, including regions like Singapore. Led by managing director Martin Akhavan, Anthro Ventures offers a hands-on approach, guiding their portfolio companies through growth and market dynamics. They tend to favor companies that present a clear path to scalability and that align with their mission of "humanizing healthcare." Startups looking to partner with Anthro should demonstrate both technological innovation and a strong potential to drive down healthcare costs.